pamidronate has been researched along with Liver Dysfunction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spirlandeli, AL | 1 |
| Dick-de-Paula, I | 1 |
| Zamarioli, A | 1 |
| Jorgetti, V | 1 |
| Ramalho, LNZ | 1 |
| Nogueira-Barbosa, MH | 1 |
| Volpon, JB | 1 |
| Jordão, AA | 1 |
| Cunha, FQ | 1 |
| Fukada, SY | 1 |
| de Paula, FJA | 1 |
| Haykal, T | 1 |
| Sundus, S | 1 |
| Bachuwa, G | 1 |
| Danish, R | 1 |
| Attard, TM | 1 |
| Dhawan, A | 1 |
| Kaufman, SS | 1 |
| Collier, DS | 1 |
| Langnas, AN | 1 |
3 other studies available for pamidronate and Liver Dysfunction
| Article | Year |
|---|---|
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling | 2017 |
Primary isolated hepatosplenic sarcoidosis mimicking malignancy and causing symptomatic hypercalcaemia.
Topics: Aftercare; Aged; Bone Density Conservation Agents; Diagnosis, Differential; Female; Humans; Hypercal | 2019 |
Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation.
Topics: Child; Child, Preschool; Diphosphonates; Drug Administration Schedule; Female; Humans; Hypercalcemia | 1998 |